Completion of SON-1010 (IL12-FHAB) monotherapy dose escalation in Phase 1 SB101 trial; Stable disease (SD) at four months post-initiation of ...

GLP-1) receptor agonists, which are used to treat type 2 diabetes and/or obesity, were linked to vision problems in a small study. Here's what doctors have to say.

Use precise geolocation data and actively scan device characteristics for identification. This is done to store and access ...

Comedian George Lopez’s recent appearance at The Jennifer Hudson Show has left his fans and followers stunned.

Analysts said Nevro’s valuation was “inexpensive,” but the spinal cord stimulation business can benefit from Globus’ scale ...

After talking to your physician, there are a few things you can do to cope with shingles at home. Get enough rest. Use ...

Neuropathy, a debilitating condition affecting millions worldwide, can significantly impair daily life and well-being.

Cosmos Health (COSM) announced that its wholly owned subsidiary, Cana Laboratories, has entered into a new long-term ten-year contract ...

Cosmos Health Inc. (NASDAQ:COSM) shares are trading slightly lower on Friday. The company revealed that its wholly owned subsidiary, Cana Laboratories, has entered into a ten-year contract ...

The phase 2 REST trial by Frida Bugge Askeland and colleagues, reported in The Lancet Haematology, provides insight into ...

Recent studies reveal a concerning trend of vision loss among patients using Ozempic and other weight loss products, raising ...

Patients with BRAF V600E-mutated metastatic colorectal cancer experienced improved responses when treated with Braftovi plus Erbitux and mFOLFOX6.